Canada’s Drug Agency 2024-25 Annual Report

Canada’s Drug Agency 2024-25 Annual Report

Canada’s Drug Agency 2024–2025 Annual Report, Shaping Change, is here. The theme this year, “Shaping Change,” aligns with our new strategic plan and reflects on a year of bringing to life our new name and enhanced role as Canada’s Drug Agency (CDA-AMC). In addition to...
Preparing for End-of-Life

Preparing for End-of-Life

MPS families carry a weight that others may never fully understand. From the moment of diagnosis, they’re asked to hold two truths simultaneously: to hope fiercely for their children while also confronting the reality that MPS can shorten their lives. It’s...
Health Canada’s special drug access program

Health Canada’s special drug access program

Did you know…If you’re a health care professional, you can request a drug that is not available for sale in Canada through the Special Access Program (SAP). Your request must be for treating a patient with a serious or life-threatening condition where...